Literature DB >> 7944658

Selective preservation of infected prosthetic arterial grafts. Analysis of a 20-year experience with 120 extracavitary-infected grafts.

K D Calligaro1, F J Veith, M L Schwartz, J Goldsmith, R P Savarese, M J Dougherty, D A DeLaurentis.   

Abstract

OBJECTIVE: The authors report on their 20-year experience with 120 patients with infected extracavitary prosthetic arterial grafts (95 polytetraflouroethylene, 25 Dacron). Throughout this experience, an effort was made, when appropriate, to salvage all or a portion of these infected grafts.
METHODS: When patients had arterial bleeding (20 cases) or systemic sepsis (6 cases), immediate graft excision was performed. When the infected graft was occluded (43 cases), subtotal graft excision was performed, leaving an oversewn 2- to 3-mm graft remnant to maintain patency of the artery. Complete graft preservation was attempted in 51 cases in which the graft was patent, the patient was not septic, and the anastomoses were intact. Aggressive operative wound debridement was repeated, as necessary, to achieve wound healing. The preferred method of revascularization, when necessary, included secondary bypasses tunneled through uninfected (often lateral) routes. Follow-up averaged 3 years (range, 1 month-20 years).
RESULTS: This strategy resulted in a hospital mortality of 12% (14/120) and a hospital amputation rate in survivors of 13% (14/106 threatened limbs). Of the surviving patients treated by complete graft preservation, the hospital amputation rate was only 4% (2/45) and long-term complete graft preservation was successful in 71% (32/45) of cases. Partial graft preservation also proved successful in 85% (35/41) of surviving patients who had occluded grafts. Successful complete graft preservation was as likely when gram-negative or gram-positive bacteria were cultured from the wound, with the exception of Pseudomonas (successful graft preservation in only 40% [4/10] of cases).
CONCLUSION: Based on this 20-year experience, the authors conclude that selective partial or complete graft preservation represents a simpler and better method of managing infected extracavitary prosthetic grafts than routine total graft excision.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7944658      PMCID: PMC1234416          DOI: 10.1097/00000658-199410000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  33 in total

1.  Management of sepsis complicating arterial reconstructive surgery.

Authors:  R S SHAW; A E BAUE
Journal:  Surgery       Date:  1963-01       Impact factor: 3.982

2.  Clinical Experience with Management of the Infected Dacron Graft.

Authors:  S C Carter; A Cohen; T J Whelan
Journal:  Ann Surg       Date:  1963-08       Impact factor: 12.969

3.  Autogenous tissue reconstruction in the management of infected prosthetic grafts.

Authors:  W K Ehrenfeld; B G Wilbur; C N Olcott; R J Stoney
Journal:  Surgery       Date:  1979-01       Impact factor: 3.982

4.  A modified method for management of prosthetic graft infections involving an anastomosis to the common femoral artery.

Authors:  K D Calligaro; F J Veith; S K Gupta; E Ascer; A M Dietzek; C D Franco; K R Wengerter
Journal:  J Vasc Surg       Date:  1990-04       Impact factor: 4.268

5.  In situ replacement of vascular prostheses infected by bacterial biofilms.

Authors:  D F Bandyk; T M Bergamini; E V Kinney; G R Seabrook; J B Towne
Journal:  J Vasc Surg       Date:  1991-05       Impact factor: 4.268

6.  In situ replacement of infected vascular prostheses with rifampin-soaked vascular grafts: early results.

Authors:  G Torsello; W Sandmann; A Gehrt; R M Jungblut
Journal:  J Vasc Surg       Date:  1993-04       Impact factor: 4.268

7.  Partial replacement of an infected arterial graft by a new prosthetic polytetrafluoroethylene segment: a new therapeutic option.

Authors:  J H Miller
Journal:  J Vasc Surg       Date:  1993-03       Impact factor: 4.268

8.  In situ allograft replacement of infected infrarenal aortic prosthetic grafts: results in forty-three patients.

Authors:  E Kieffer; A Bahnini; F Koskas; C Ruotolo; D Le Blevec; D Plissonnier
Journal:  J Vasc Surg       Date:  1993-02       Impact factor: 4.268

9.  Infected femorodistal bypass: is graft removal mandatory?

Authors:  K J Cherry; C F Roland; P C Pairolero; J W Hallett; N B Meland; J M Naessens; P Gloviczki; T C Bower
Journal:  J Vasc Surg       Date:  1992-02       Impact factor: 4.268

10.  Mortality and limb loss with infected infrainguinal bypass grafts.

Authors:  M J Kikta; S F Goodson; R A Bishara; J P Meyer; J J Schuler; D P Flanigan
Journal:  J Vasc Surg       Date:  1987-04       Impact factor: 4.268

View more
  8 in total

1.  Intra-arterial Device Infections.

Authors:  Vera S. Antonios; Larry M. Baddour
Journal:  Curr Infect Dis Rep       Date:  2004-08       Impact factor: 3.725

Review 2.  Surgical site infections in older adults: epidemiology and management strategies.

Authors:  Michael H Young; Laraine Washer; Preeti N Malani
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  Surgical and antimicrobial treatment of prosthetic vascular graft infections at different surgical sites: a retrospective study of treatment outcomes.

Authors:  Stefan Erb; Jan A Sidler; Luigia Elzi; Lorenz Gurke; Manuel Battegay; Andreas F Widmer; Maja Weisser
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

4.  Infected Groin (Graft/Patch): Managed with Sartorious Muscle Flap.

Authors:  Dong Yeon Ryu; Hyuk Jae Jung; Venkaesh G Ramaiah; Julio A Rodriguez-Lopez; Sang Su Lee
Journal:  Vasc Specialist Int       Date:  2016-03-31

5.  Cost-Utility Analysis: Sartorius Flap versus Negative Pressure Therapy for Infected Vascular Groin Graft Managment.

Authors:  Abhishek Chatterjee; David Macarios; Leah Griffin; Tomasz Kosowski; Bryan J Pyfer; Anaeze C Offodile; Daniel Driscoll; Sirish Maddali; John Attwood
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-12-09

6.  Complex treatment of vascular prostheses infections.

Authors:  Octavian Andercou; Dorin Marian; Gabriel Olteanu; Bogdan Stancu; Beatrix Cucuruz; Thomas Noppeney
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

7.  Prosthetic vascular graft infection: a multi-center review of surgical management.

Authors:  Eleonore Zetrenne; Bryan C McIntosh; Mark H McRae; Richard Gusberg; Gregory R D Evans; Deepak Narayan
Journal:  Yale J Biol Med       Date:  2007-09

8.  Negative pressure wound therapy with intermittent instillation of rifampin for the treatment of an infected vascular bypass graft.

Authors:  Chrisovalantis Lakhiani; Christopher M Fleury; Cara K Black; David E Janhofer; Cameron Akbari; Karen Kim Evans
Journal:  J Vasc Surg Cases Innov Tech       Date:  2019-10-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.